Filtered By:
Condition: Congestive Heart Failure
Drug: Meridia
This page shows you your search results in order of date.
Order by Relevance | Date
Total 14 results found since Jan 2013.
Dream Body 450mg, Dream Body Extreme Gold 800mg, Dream Body Advanced 400mg: Recall - Undeclared Drug Ingredient
Sibutramine may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Source: FDA MedWatch Safety Alert - July 5, 2016 Category: American Health Source Type: alerts
Step 2 60 Gold by The Body Shot Bar: Recall - Undeclared Drug Ingredients
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Source: FDA MedWatch Safety Alert - June 7, 2016 Category: American Health Source Type: alerts
Slim-Vie: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - November 26, 2014 Category: American Health Source Type: news
Bee Thin: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - November 24, 2014 Category: American Health Source Type: news
Super Extreme Accelerator: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - November 24, 2014 Category: American Health Source Type: news
Bee Slim: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - November 24, 2014 Category: American Health Source Type: news
V26 Slimming Coffee: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - November 5, 2014 Category: American Health Source Type: news
Metformin associated with better cardiovascular outcomes than other glycaemic therapies
Context A question exists as to whether the outcome of glycaemic treatment of diabetes varies with the agent used; speculation surrounds whether metformin might be preferable to other treatments. Methods Ghotbi and colleagues performed an epidemiological analysis of 8192 obese patients with diabetes at increased cardiovascular risk participating in the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Mortality and a combined cardiovascular outcome of non-fatal myocardial infarction, non-fatal stroke, resuscitation after cardiac arrest or cardiovascular death were compared among those receiving one of the following interv...
Source: Evidence-Based Medicine - May 19, 2014 Category: Internal Medicine Authors: Bloomgarden, Z. T. Tags: Smoking and tobacco, Epidemiologic studies, Drugs: cardiovascular system, Heart failure, Stroke, Hypertension, Diet, Obesity (nutrition), Ischaemic heart disease, Diabetes, Health education, Smoking Therapeutics Source Type: research
Bella Vi Brand Products by Pure Edge Nutrition: Recall - Undeclared Drug Ingredients
Sibutramine can increase blood pressure and/or pulse rate in some patients and may present a risk for those with a history of coronary artery disease, congestive heart failure, arrhymias or stroke.
Source: FDA MedWatch - March 26, 2014 Category: American Health Source Type: news
Vitaccino Coffee: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients, and may also present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - March 19, 2014 Category: American Health Source Type: news
Dream Body Slimming Capsule: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - January 22, 2014 Category: American Health Source Type: news
Magic Slim: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - January 22, 2014 Category: American Health Source Type: news
JaDera and Xiyouji Qingzhi Dietary Supplements by Dolphin Intertrade Corp.: Recall - Undeclared Drug Ingredient
Products have been found to contain undeclared Sibutramine, known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Source: FDA MedWatch - June 28, 2013 Category: American Health Source Type: news
Maxiloss Weight Advanced Softgels: Recall - Undeclared Drug Ingredient
Product marketed as dietary supplement contains drug ingredient Sibutramine, and may present a significant risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Source: FDA MedWatch - February 25, 2013 Category: American Health Source Type: news
